Royal Bank of Canada’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $109M | Sell |
174,515
-176,656
| -50% | -$120M | 0.02% | 670 |
|
|
2026
Q1 | $271M | Buy |
351,171
+5,952
| +2% | +$4.56M | 0.05% | 339 |
|
|
2025
Q4 | $266M | Sell |
345,219
-27,876
| -7% | -$18.9M | 0.04% | 345 |
|
|
2025
Q3 | $210M | Sell |
373,095
-11,784
| -3% | -$6.66M | 0.03% | 414 |
|
|
2025
Q2 | $202M | Buy |
384,879
+181,682
| +89% | +$101M | 0.04% | 395 |
|
|
2025
Q1 | $129M | Sell |
203,197
-85,740
| -30% | -$59M | 0.03% | 460 |
|
|
2024
Q4 | $206M | Buy |
288,937
+27,497
| +11% | +$23.1M | 0.04% | 353 |
|
|
2024
Q3 | $275M | Buy |
261,440
+62,494
| +31% | +$69.5M | 0.06% | 291 |
|
|
2024
Q2 | $209M | Buy |
198,946
+60,392
| +44% | +$58.5M | 0.05% | 316 |
|
|
2024
Q1 | $133M | Sell |
138,554
-123,237
| -47% | -$117M | 0.03% | 416 |
|
|
2023
Q4 | $230M | Buy |
261,791
+101,858
| +64% | +$83.9M | 0.05% | 296 |
|
|
2023
Q3 | $132M | Buy |
159,933
+6,991
| +5% | +$5.49M | 0.04% | 394 |
|
|
2023
Q2 | $110M | Sell |
152,942
-27,883
| -15% | -$21.5M | 0.03% | 456 |
|
|
2023
Q1 | $149M | Sell |
180,825
-117,229
| -39% | -$88.4M | 0.04% | 370 |
|
|
2022
Q4 | $215M | Sell |
298,054
-25,495
| -8% | -$18.8M | 0.06% | 279 |
|
|
2022
Q3 | $223M | Sell |
323,549
-13,074
| -4% | -$8.23M | 0.07% | 238 |
|
|
2022
Q2 | $199M | Buy |
336,623
+22,270
| +7% | +$14.5M | 0.06% | 275 |
|
|
2022
Q1 | $220M | Buy |
314,353
+36,234
| +13% | +$22.9M | 0.05% | 290 |
|
|
2021
Q4 | $176M | Buy |
278,119
+81,162
| +41% | +$49.9M | 0.04% | 359 |
|
|
2021
Q3 | $119M | Buy |
196,957
+96,126
| +95% | +$59.7M | 0.03% | 436 |
|
|
2021
Q2 | $56.3M | Sell |
100,831
-1,125
| -1% | -$570K | 0.02% | 692 |
|
|
2021
Q1 | $48.2M | Sell |
101,956
-63,374
| -38% | -$30.9M | 0.01% | 728 |
|
|
2020
Q4 | $79.9M | Buy |
165,330
+44,708
| +37% | +$24.1M | 0.02% | 521 |
|
|
2020
Q3 | $67.5M | Buy |
120,622
+12,415
| +11% | +$7.53M | 0.02% | 503 |
|
|
2020
Q2 | $67.5M | Buy |
108,207
+25,862
| +31% | +$14.7M | 0.03% | 474 |
|
|
2020
Q1 | $40.2M | Buy |
82,345
+12,107
| +17% | +$4.99M | 0.02% | 572 |
|
|
2019
Q4 | $26.4M | Sell |
70,238
-31,655
| -31% | -$10.7M | 0.01% | 981 |
|
|
2019
Q3 | $28.3M | Buy |
101,893
+29,932
| +42% | +$8.86M | 0.01% | 862 |
|
|
2019
Q2 | $22.5M | Sell |
71,961
-54,339
| -43% | -$18.1M | 0.01% | 1011 |
|
|
2019
Q1 | $51.9M | Buy |
126,300
+41,108
| +48% | +$16.9M | 0.02% | 560 |
|
|
2018
Q4 | $31.8M | Buy |
85,192
+512
| +0.6% | +$187K | 0.02% | 729 |
|
|
2018
Q3 | $34.2M | Buy |
84,680
+16,828
| +25% | +$6.4M | 0.01% | 794 |
|
|
2018
Q2 | $23.4M | Sell |
67,852
-23,844
| -26% | -$7.46M | 0.01% | 977 |
|
|
2018
Q1 | $31.6M | Buy |
91,696
+16,566
| +22% | +$5.76M | 0.01% | 802 |
|
|
2017
Q4 | $28.2M | Buy |
75,130
+9,216
| +14% | +$3.73M | 0.01% | 918 |
|
|
2017
Q3 | $29.5M | Sell |
65,914
-1,550
| -2% | -$738K | 0.01% | 834 |
|
|
2017
Q2 | $33.1M | Buy |
67,464
+2,802
| +4% | +$1.23M | 0.02% | 743 |
|
|
2017
Q1 | $25.1M | Sell |
64,662
-7,061
| -10% | -$2.62M | 0.01% | 883 |
|
|
2016
Q4 | $26.3M | Buy |
71,723
+13,658
| +24% | +$5.19M | 0.01% | 872 |
|
|
2016
Q3 | $23.3M | Buy |
58,065
+5,237
| +10% | +$2.1M | 0.01% | 910 |
|
|
2016
Q2 | $18.4M | Sell |
52,828
-10,903
| -17% | -$4.2M | 0.01% | 1014 |
|
|
2016
Q1 | $23M | Sell |
63,731
-2,817
| -4% | -$1.16M | 0.01% | 853 |
|
|
2015
Q4 | $36.1M | Buy |
66,548
+14,554
| +28% | +$7.89M | 0.02% | 598 |
|
|
2015
Q3 | $24.2M | Sell |
51,994
-20,259
| -28% | -$10.9M | 0.02% | 667 |
|
|
2015
Q2 | $36.9M | Sell |
72,253
-631
| -0.9% | -$308K | 0.03% | 513 |
|
|
2015
Q1 | $32.9M | Sell |
72,884
-19,257
| -21% | -$8.16M | 0.02% | 563 |
|
|
2014
Q4 | $37.8M | Buy |
92,141
+7,885
| +9% | +$3.1M | 0.02% | 539 |
|
|
2014
Q3 | $30.4M | Buy |
84,256
+45,918
| +120% | +$15.4M | 0.02% | 592 |
|
|
2014
Q2 | $10.8M | Sell |
38,338
-41,061
| -52% | -$12.2M | 0.01% | 1180 |
|
|
2014
Q1 | $23.8M | Sell |
79,399
-20,461
| -20% | -$6.3M | 0.02% | 666 |
|
|
2013
Q4 | $27.5M | Buy |
99,860
+9,021
| +10% | +$2.59M | 0.02% | 620 |
|
|
2013
Q3 | $28.4M | Buy |
90,839
+31,268
| +52% | +$8.22M | 0.02% | 553 |
|
|
2013
Q2 | $13.4M | Buy |
+59,571
| New | +$13.9M | 0.01% | 881 |
|
Other funds holding REGN
Royal Bank of Canada's REGN Position: Q2 2026 in Review
Royal Bank of Canada reduced its Regeneron Pharmaceuticals (REGN) stake by 50% in Q2 2026, selling an estimated $120M and leaving 174,515 shares worth $109M. The position accounts for 0.02% of the portfolio, ranked #670.
Royal Bank of Canada first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $275M in Q3 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Royal Bank of Canada held 174,515 shares of Regeneron Pharmaceuticals worth $109M as of Q2 2026.
- Royal Bank of Canada sold 176,656 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $120M.
- Regeneron Pharmaceuticals made up 0.02% of Royal Bank of Canada's portfolio in Q2 2026, its #670 holding.
- Royal Bank of Canada first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Royal Bank of Canada's Regeneron Pharmaceuticals position peaked at $275M in Q3 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.